Related by context. All words. (Click for frequent words.) 71 CELLO 70 phase IIIb 70 ASTEROID 69 prospective multicenter 69 multicentre randomized 69 STENT 69 Prospective Randomized 69 PFO migraine 69 PREVAIL 68 PHASE III 68 multicenter prospective 68 Multicenter 67 PERSEUS 67 prospective randomized controlled 67 Eluting Coronary Stent System 66 Randomized Evaluation 66 GORE VIABAHN Endoprosthesis 66 Ranolazine 66 Endoprosthesis 66 RADIANT 65 Acute Myocardial Infarction 65 fosbretabulin 65 Pivotal Trial 65 DUROS 65 Sirolimus eluting Coronary Stent 65 Carotid 65 Drug Eluting Stents 65 RIBBON 65 Heparin Bioactive Surface 65 MINDSET 65 REVIVE 65 MIST II 65 Alair System 65 PROTEGE 65 RELIANT 65 carotid artery stenting CAS 65 multicenter randomized controlled 65 PREDICTIVE 65 pain palliation 65 ACCOMPLISH 64 TRANSFORMS 64 WallFlex Biliary RX 64 Acute Ischemic Stroke 64 multicenter randomized clinical 64 RE LY 64 Sirolimus eluting 64 prospective randomized multicenter 64 sirolimus eluting 64 DIAGNOSTIC 64 EchoCRT 64 EURIDIS 64 everolimus eluting stents 64 multicenter randomized placebo controlled 64 ONTARGET 64 Tryton Side Branch 64 paclitaxel eluting 64 ARBITER 6 64 renal artery stenting 64 ATTRACT 64 Phase III Clinical Trial 64 Phase IIIb clinical 64 randomized Phase IIb 64 CardioFit 64 GOUT 64 substudy 64 HeartNet 64 Nitinol Stent 64 NAVISTAR R 64 nonrandomized 64 Fondaparinux 64 TM Everolimus Eluting 64 Eluting Stent 64 NAVIGATOR 64 randomized controlled clinical 64 ExTRACT TIMI 64 Percutaneous Transluminal Coronary Angioplasty 64 carotid endarterectomy CEA 64 STRIDE PD 64 RE COVER 64 ABSORB 63 Carotid Revascularization Endarterectomy vs. 63 phase IIa 63 prospective multicenter randomized 63 BOLDER 63 CARE HF 63 Cardiac Resynchronization Therapy 63 Aflibercept 63 GORE TAG Device 63 Patency 63 Polyzene R F 63 BLOSSOM 63 TMC# C# 63 POISE 63 MEND CABG 63 multicenter clinical 63 Infarct 63 STARFlex R 63 UNLOAD 63 ACCLAIM 63 HuMax EGFr 63 HydroCoil 63 eluting stent 63 Prospective Multicenter 63 Phase IIIb 63 EmbraceAC 63 ASSURE 63 XIENCE TM 63 phase IIb clinical 63 Pertuzumab 63 HepaSphere 63 CABANA 63 Percutaneous Tibial Nerve Stimulation 63 PRE SURGE 63 ADVANCE PD 63 COMPANION 63 PFO closure 63 sorafenib Nexavar 63 tanespimycin 63 Zenvia Phase III 62 teriflunomide 62 analgesic efficacy 62 Randomized controlled 62 BENICAR HCT 62 ROADMAP 62 pharmacokinetic PK study 62 phase IIa clinical 62 FDA APPROVES 62 randomized multicenter 62 CD HORIZON 62 catheter occlusion 62 Phase 2b kidney transplant 62 ENDEAVOR IV 62 oral ridaforolimus 62 NEVO 62 HALTS 62 IN PATIENTS WITH 62 STUDY RESULTS 62 SPIRIT FIRST 62 Randomized Clinical Trial 62 Vascugel ® 62 TAXUS ATLAS 62 TO AVOID PREGNANCY WHILE 62 HYPERTENSION 62 V Everolimus Eluting Coronary 62 GORE VIABAHN ® 62 icatibant 62 EVOLUTION 62 Pivotal Phase III 62 Aggressive Drug Evaluation 62 CIMZIA TM certolizumab pegol 62 II Clinical Trial 62 IL# PE#QQR 62 Coronary Stent 62 BioSTAR TM 62 ENDEAVOR III 62 Pivotal Study 62 Combo Stent 62 QuadraSphere 62 Long Term Efficacy 62 everolimus eluting stent 62 TAXUS Element Paclitaxel Eluting 62 TLK# 62 Fully Covered Stent 62 IN.PACT 62 prospective randomized 62 placebo controlled clinical 62 NEVO TM 62 Phase IIb Trial 62 SANTE 62 metastatic malignant 62 CLINICAL TRIAL 62 REALITY Trial 62 Tanespimycin 62 Interferon beta 1a 62 Biolimus A9 62 PROMUS 62 Cotavance 62 liposomal formulation 62 reslizumab 61 Coronary Artery Bypass Graft 61 platelet inhibitor 61 ARBITER 61 Randomised 61 RE LY ® 61 Adhesion Barrier 61 Bivalirudin 61 MERLIN TIMI 61 Intervention Effectiveness 61 pertuzumab 61 ENVISION 61 FREEDOMS 61 randomized Phase III 61 Bronchial Thermoplasty 61 drug eluting balloon 61 Degarelix 61 TM Drug Eluting 61 Ablation System 61 MIVI III 61 randomized multicenter trial 61 Stent System 61 Ophena 61 ZOLINZA 61 nab paclitaxel 61 Prostate AdenoCarcinoma Treatment 61 Phase #b/#a clinical 61 Everolimus Eluting Coronary Stent 61 NATRECOR ® 61 AIM HIGH 61 Inhalation Solution 61 Endovascular System 61 evaluating Actimmune 61 ILLUMINATE 61 multicenter Phase II 61 STARFlex 61 Combination REOLYSIN R 61 APPRAISE 61 superficial femoral 61 Pemetrexed 61 Initiate Clinical Trial 61 Initiated Phase 61 APTIVUS 61 Drug Eluting 61 Dual Opioid 61 Apixaban 61 Olmesartan 61 Left Ventricular Dysfunction 61 Dose Ranging Study 61 ORENCIA ® 61 vidofludimus 61 colesevelam HCl 61 multicenter randomized 61 phase IIb study 61 Telmisartan 61 TREATMENT OF 61 Emboli Capture Guidewire 61 Zilver PTX 61 SABCS 61 PRoFESS 61 Intravascular 61 BRIM2 61 VerifyNow 61 SORT OUT 61 Prospective Randomized Trial 61 carotid artery stenting 61 AZILECT ® 61 Pivotal Clinical Trial 61 CYPHER R Sirolimus eluting 61 Embolic Protection System 61 CONQUER 61 Ozurdex 61 mechanical thrombectomy 61 subanalysis 61 prospectively randomized 61 CHAMPION PCI 61 TEST OF 61 PROWESS 61 CONTRAINDICATIONS 61 ARIXTRA 60 Meets Primary Endpoint 60 Aneurysm Repair 60 COMFORT II 60 Microwave Ablation System 60 oral Xeloda 60 Phase Ib study 60 CHARISMA 60 Benign Prostatic Hyperplasia BPH 60 THAT ARE DIFFICULT TO 60 Trandolapril 60 Orqis Medical 60 neratinib 60 Dabigatran 60 tiuxetan 60 NP2 Enkephalin 60 Phase Ib clinical 60 candesartan cilexetil 60 Phase IIB 60 Surgical Mesh 60 MAGE A3 ASCI 60 Phase 1b trial 60 relapsing multiple sclerosis 60 TROPIC 60 TARGIT 60 Daclizumab 60 Adalimumab 60 VITALITY 60 OZURDEX 60 See CLINICAL PHARMACOLOGY 60 OmniWave 60 PICSO ® 60 COMPARE 60 bortezomib Velcade 60 MEND CABG II 60 Unstable Angina 60 Vascular Wrap 60 multicenter multinational 60 PROMUS TM 60 ZD# [001] 60 NEVO RES 60 Phase 1a clinical 60 Mycophenolate Mofetil 60 AIR2 Trial 60 Ranibizumab 60 registrational Phase 60 STICH 60 Stent Graft 60 Refractory Angina 60 EXPAREL ™ 60 TAXUS Stent 60 REFLEX 60 Abciximab 60 PROPATEN Bioactive Surface 60 Xanafide 60 APEX PD 60 XIENCE V Everolimus Eluting 60 dual endothelin receptor antagonist 60 Phase III confirmatory 60 TAXUS Liberte Stent 60 cardiac resynchronisation therapy 60 Clinical Trial Evaluating 60 urethral bulking agent 60 Vascular Closure Device 60 Val HeFT 60 CA9 SCAN 60 Phase Ib II 60 IN.PACT Falcon 60 Phase IIa trial 60 Study Evaluating 60 Cypher Sirolimus 60 Protelos 60 Fibrin Pad 60 Drug Eluting Stent System 60 acute peripheral arterial 60 RE MODEL 60 interferon gamma 1b 60 ASSERT 60 Catheter System 60 Phase 2b Study 60 AVANDIA 60 Controlled Trial 60 prospective multicentre 60 FASLODEX 60 Optical Coherence Tomography 60 prospective randomized placebo 60 Abbott HUMIRA 60 lexidronam injection 60 Embolic Protection Device 60 Metabolic Efficiency 60 ClosureFAST 60 Chronic Heart Failure 60 Neovasc Reducer 60 efficacy tolerability 60 EVEREST II 60 Abdominal Stent Graft 60 Teysuno 60 phase IIb 60 dose escalation Phase 60 ENDURE 60 ENDEAVOR II 60 zotarolimus eluting stent 60 ADAGIO study 60 LUMINATE 60 NeuroStar TMS Therapy 60 RENAL 60 XIENCE 60 Liposomal 60 PEGylated interferon beta 1a 60 EINSTEIN DVT 60 liposome injection 60 Platelet Inhibition 60 PROMUS ® 60 KRN# 60 sirolimus eluting stents 60 ZoMaxx 60 Zarnestra 60 Cellulaze 60 ZACTIMA 60 DEFER 60 rosuvastatin #mg 60 Long Lesion 60 Intravitreal 60 ENDEAVOR 60 bevacizumab Avastin 60 Bosentan 60 BOLDER II 60 Phase III multicenter 60 BioMatrix 60 Phase III pivotal 60 Dr. Fehlings 60 pharmacokinetic PK 60 GORE ® 60 PROMUS Element Everolimus Eluting 60 Clinical Evaluation 60 Cardiac Allograft Rejection 60 multicentre randomized controlled 59 Juvederm Ultra 59 Renal Artery 59 Microplasmin 59 Amrubicin 59 Phase IIb Clinical Trial 59 Aortic Stenosis 59 Oxiplex 59 RE LY trial 59 STUDY OF 59 novel oral anticoagulant 59 Clolar ® 59 PEG IFN 59 PROMUS Element Stent 59 masked placebo controlled 59 TriActiv R 59 Isolagen Therapy 59 MiStent DES 59 Resynchronization 59 Dabigatran etexilate 59 THYROID 59 Bepreve TM 59 Tyrosine Kinase Inhibitor 59 CLARITY study 59 Dual Antiplatelet Therapy 59 PROMUS Element 59 Artificial Disc 59 GAMMAGARD 59 VisuMax 59 Thrombolysis 59 Cimzia TM 59 clevidipine 59 CABERNET 59 RE SURGE 59 drug eluting stent DES 59 Phase 2a Clinical Trial 59 TREATMENTS 59 Pivotal Phase 59 THE STUDY 59 Surgical Ablation 59 CRLX# 59 uricase 59 Smartlipo MPX 59 Dupuytren Contracture 59 Biphasic 59 HDL Selective Delipidation 59 IMPLANT 59 orally inhaled migraine 59 ALLEVIATE 59 bioabsorbable stent 59 Phase IIIb study 59 label multicenter Phase 59 pioglitazone HCl 59 randomized controlled multicenter 59 Surgical Sealant 59 biliary tract cancer 59 ToGA 59 myocardial revascularization 59 RAVEL 59 HORMONE 59 viral kinetic 59 Phase III randomized controlled 59 Edwards SAPIEN valve 59 SIR Spheres 59 Benign Prostatic Hyperplasia 59 MammoSite RTS 59 GORE TAG ® 59 recurrent GBM 59 transesophageal 59 ClearPath HDR 59 Endoluminal 59 EOquin TM 59 transcranial Doppler ultrasound 59 concurrent chemoradiation 59 Phase III randomized 59 IIIa inhibitor 59 COPERNICUS 59 Phase III ThermoDox 59 ID NCT# 59 Valsartan 59 Tarceva TM 59 TAXUS TM 59 DA VINCI 59 PREVENT IV 59 Tocilizumab 59 ALVESCO R 59 MGuard ™ 59 lapatinib Tykerb 59 VADT 59 AFRS TM 59 PDX pralatrexate 59 thorough QT 59 PEAK PlasmaBlade 59 Stent Restenosis 59 CoreValve System 59 Catena ® 59 Trobalt 59 BIBW 59 Phase 2b Clinical Trial 59 Pharmacokinetic Study 59 prospective multicenter study 59 multicenter Phase III 59 Tezampanel 59 THERAPEUTICS 59 Phase #b/#a 59 fallopian tube cancers 59 bi ventricular pacing 59 Elagolix 59 EFAPROXYN 59 THE ORLANDO FLA. 59 HEART DISEASE 59 stent DES 59 Quinamed 59 bazedoxifene conjugated estrogens 59 combretastatin A4 phosphate CA4P 59 ExAblate R 59 CARDIOVASCULAR 59 CYPHER SELECT TM 59 Diabetic Macular Edema DME 59 GRAVITAS trial 59 mertansine 59 placebo controlled Phase III 59 Endeavor Drug Eluting 59 Phase 1b dose escalation 59 BENICAR 59 CINQUIL 59 ALVESCO ® 59 Endeavor drug eluting 59 CLiRpath 59 symptomatic paroxysmal AF 59 thrombus aspiration 59 anti arrhythmic drug 59 CHARISMA trial 59 Resolute stent 59 Glatiramer Acetate 59 Vidaza azacitidine 59 brivaracetam 59 arzoxifene 59 photoprotective drug 59 bioresorbable polymer 59 Overactive Bladder 59 placebo controlled Phase 59 REALIZE 59 Phase 2a clinical 59 phase Ib 59 MyoCell 59 Resurfacing System 59 IMPACTS 59 Dasatinib 59 NEXIUM 59 ALLEGRO 59 DAPT 59 Cardiotoxicity 59 double blinded randomized 59 WATCHMAN 59 trial evaluating PRX# 59 ALA PDT 59 Mobi C 59 VESTAsync 59 Self Expanding Stent 59 Phase 2a trial 59 Accelerated Partial Breast Irradiation 59 Clinical Outcomes Utilizing Revascularization 59 liposomal doxorubicin 59 TAXUS Liberte Long 59 Cellvizio R 59 mm Stent 59 Patients Treated With 59 Oral Mucositis 59 Gliadel Wafer 59 CRMD# 59 SPIRIT IV 59 Pulmonary Arterial Hypertension 59 OBJECTIVES 59 Diabetic Neuropathy 59 Carvedilol 59 MADIT 59 SYNTAX 59 topical diclofenac 59 Genous stent 59 Sublative Rejuvenation 59 EnteroMedics proprietary neuroblocking technology 59 SUCCEED trial 59 fully bioabsorbable 59 AVASTIN 59 undergoing elective percutaneous 59 Eluting 59 RECOVER 58 INITIATE 58 PressureWire 58 carotid artery stent 58 riociguat 58 TAXUS VI 58 endoluminal 58 multicentre 58 Rasilez Tekturna 58 Temsirolimus 58 Efficacy Results 58 PROMUS R 58 phase IIb III 58 generation purine nucleoside 58 Bioresorbable 58 INTRABEAM 58 Eculizumab 58 Epirubicin 58 ™ Everolimus Eluting 58 randomized controlled Phase 58 drug eluting coronary stent 58 bevacizumab Avastin ® 58 CIMZIA ™ 58 ASBMR 58 docetaxel Taxotere ® 58 AVADO 58 liposome formulation 58 REVLIMID lenalidomide 58 Myocardial Perfusion Imaging 58 Neoadjuvant 58 ADMIRE HF 58 lorcaserin Phase 58 CTO recanalization 58 Pirfenidone 58 Endologix Powerlink System 58 TOPICAL 58 EDEMA3 58 ivabradine 58 Cook Zenith TX2 58 transurethral 58 CUSTOM II 58 transoral 58 preclinical efficacy 58 sorafenib tablets 58 Carotid Stent 58 RhuDex 58 Nebulized 58 strontium ranelate 58 Dyloject TM 58 Nesiritide 58 bioabsorbable polymer 58 afamelanotide 58 prospective nonrandomized 58 pharmacokinetic PK profile 58 Cypher Stent 58 label multicenter 58 METEOR 58 EXCITE 58 mg kg BID 58 EverFlex 58 salmeterol fluticasone 58 dose escalation clinical 58 randomized blinded 58 oral rivaroxaban 58 Schizophrenia Treatment 58 everolimus eluting 58 INCB# [003] 58 Angiographic 58 occipital nerve stimulation 58 Safinamide 58 Polymer Microspheres 58 EXPAREL TM 58 SENSORS 58 Peripheral Arterial 58 HORIZONS 58 Plicator 58 evaluating tivozanib 58 treating abdominal aortic 58 rFVIIa 58 BrachySil ™ 58 Perforomist ™ Inhalation Solution 58 BioSTAR R 58 functional mitral regurgitation 58 Initiate Phase 58 Pharmacodynamics 58 Trofex 58 investigational antiplatelet 58 Metastatic Melanoma 58 TAXUS Liberte 58 Dalbavancin 58 Phase III Trial 58 Axxent R 58 LUX Lung 58 Randomized Study 58 TELCYTA 58 Dose Escalation 58 Dural Sealant 58 morphometric vertebral fractures 58 Myocet 58 NCIC CTG 58 Alocrest 58 assessing T DM1 58 BrachySil TM 58 RECORD1 58 paclitaxel eluting stents 58 ENLIGHT 58 Percutaneous vertebroplasty 58 Bone Graft 58 TASKi2 58 RESOLUTE clinical 58 Bare Metal Stent 58 Phase 2b study 58 angiotensin receptor blocker ARB 58 oral anticoagulant 58 crizotinib PF # 58 Hyphanox 58 Coronary Stent System 58 CUPID 58 efficacy endpoint 58 CoFactor 58 Tolvaptan 58 cetuximab Erbitux ® 58 neurologic progression 58 Clinical Outcome 58 GORE TAG 58 Tyrima 58 SYNERGY Stent 58 NSABP B 58 Azedra 58 CYPHER 58 Betaferon R 58 REG1 58 TG MV 58 ABSORB trial 58 bifurcation stent 58 Myocardial Infarction Study 58 TUMT 58 Tiotropium 58 placebo controlled randomized 58 zotarolimus 58 antiarrhythmic drug 58 1 DAY ACUVUE 58 MADIT II 58 viral kinetics 58 Phase 1b clinical 58 Rilonacept 58 MyoCell SDF 1 58 pan HDAC inhibitor 58 NICE SUGAR 58 FinESS 58 Randomized Phase 58 Aplidin R 58 non valvular atrial 58 multicenter randomized double 58 elagolix 58 antiplatelet agent 58 PRECISE trial 58 unfractionated heparin UFH 58 biodegradable implant 58 Clinical Trial Results 58 LEUKINE 58 double blinded placebo 58 noninferiority 58 endoluminal stent graft 58 transesophageal echocardiography TEE 58 Traficet EN 58 Oral Fingolimod 58 International Verapamil SR 58 AIR CF1 58 Teriflunomide 58 ROCKET AF 58 AZOR 58 Capesaris 58 Rubicon Filter 58 ACCORD Lipid 58 carotid stent 58 Antiviral Activity 58 Deforolimus 58 Xelox 58 Surgical Treatment 58 Radiofrequency Ablation 58 FDG PET imaging 58 PATENT 58 Afatinib 58 NO# [002] 58 Randomized Double blind 58 Adjuvant Treatment 58 omacetaxine mepesuccinate 58 Alfimeprase 58 CYT# QbG# 58 Demonstrates Significant 58 Trastuzumab 58 Bazedoxifene 58 APRICOT 58 MYDICAR 58 OUTCOMES 58 clinical endpoints 58 Thrombectomy 58 TAPAS 58 PressureWire Certus 58 pimecrolimus cream 58 mGluR5 negative 58 PlasmaBlade 58 STARFlex ® 58 Aliskiren 58 Diamondback #deg 58 Left Ventricular 58 SCD HeFT 58 HoFH 58 STRATUS 58 TELIGEN 58 Phase #/#a 58 ILLUSTRATE 58 DURATION 58 dermaPACE 58 balloon expandable stent 58 Glufosfamide 58 GRAVITAS 58 biologic therapy 58 VESTASYNC 58 ACUITY trial 58 ISAR TEST 58 stimulation PTNS 57 Phase III placebo controlled 57 sunitinib malate 57 Cardioblate 57 CYPHER ® Sirolimus eluting 57 evaluating carfilzomib 57 Pharmacokinetic 57 CALGB # [002] 57 APTIVUS R 57 Adjunctive 57 Adjuvant Therapy 57 COR Analyzer 57 Controlled Study 57 BARI 2D 57 Bronchoscopy 57 Adenoma Prevention 57 CBLC# 57 Androxal TM 57 Pegylated Liposomal Doxorubicin 57 StarClose 57 Echocardiographic 57 multicentre randomized double 57 REPEL CV 57 keratoplasty 57 reflux esophagitis 57 rALLy clinical trial 57 landmark ATHENA 57 Pharmacokinetic PK 57 preclinical pharmacokinetic 57 Carfilzomib 57 GP IIb IIIa inhibitors 57 Dapagliflozin 57 Infliximab 57 cediranib 57 Lenalidomide 57 satraplatin Phase 57 pharmacokinetics PK 57 RoACTEMRA 57 Stenting Trial CREST 57 Rosuvastatin 57 Pyridorin 57 MGd 57 Intravesical 57 TASKi3 57 Percutaneous Coronary Intervention 57 melphalan prednisone 57 QLT# 57 MKC# MKC# PP 57 ritonavir boosted danoprevir 57 REALISM 57 Rivaroxaban 57 Virtual Histology 57 ACOMPLIA R 57 PERSEUS clinical program 57 zonisamide SR 57 ACTOS ® 57 MATCHED 57 Lumbar Interbody Fusion 57 Onrigin 57 pivotal bioequivalence 57 ULORIC 57 HORIZONS AMI 57 ThermoDox R 57 oral FTY# 57 oral prodrug 57 IMA# 57 RHEO 57 SERENADE 57 randomized multicenter Phase III 57 INC# 57 REVLIMID R 57 TAXUS Express Stent 57 percutaneous transluminal coronary angioplasty 57 Valiant Thoracic Stent Graft 57 BAL# [002] 57 Cilostazol 57 ASCEND HF 57 Zemiva 57 FDA Approvals 57 opioid induced bowel dysfunction 57 Hormone Refractory Prostate Cancer 57 REG2 57 varespladib 57 gefitinib Iressa 57 JenaValve 57 CHAMPION PLATFORM 57 PRELUDE 57 Hycamtin ® 57 ALGRX 57 RX ACCULINK 57 Catheter Ablation 57 rt PA 57 RADIATE 57 carotid stenting 57 Golimumab 57 HORIZONS AMI trial 57 amifostine 57 DEFINITIVE 57 QTinno 57 cetuximab Erbitux 57 CAPHOSOL 57 Rheos System 57 Ambrisentan 57 PEGINTRON TM 57 Gemzar ® 57 Balloon Catheter 57 First Patient Enrolled 57 sipuleucel T 57 transabdominal 57 TRIAL OF 57 DU #b 57 Restenosis 57 Thoracic Endoprosthesis 57 Phase 2b Trial 57 LibiGel ® 57 AZILECT R 57 ASSERT trial 57 Intracoronary 57 NEW TREATMENT 57 IMPACT DCM 57 QD dosing 57 Thrombus Aspiration 57 XIENCE V PROMUS Stent 57 randomized controlled clinical trials 57 systemic immunosuppressive drugs 57 Central Retinal Vein 57 Sipuleucel T 57 percutaneous vertebroplasty 57 IMPACT IMmunotherapy 57 Sorafenib HCC Assessment 57 Lupus Nephritis 57 VICTOR E3 57 vinorelbine tartrate 57 Advanced Renal Cell 57 trabedersen 57 Multi MERCI 57 CALGB 57 SEROQUEL 57 randomized clinical 57 ibandronate 57 MabCampath 57 NeuroFlo 57 PATIENTS WHO 57 Acute Decompensated Heart Failure 57 miconazole Lauriad R 57 By JENNIFER LEARN 57 noninferior 57 MitraClip device 57 Recurrent Glioblastoma 57 R lenalidomide 57 CLARITY TIMI 57 LHRH receptor positive 57 IRESSA 57 embolic protection device 57 rFIXFc 57 gemcitabine Gemzar ® 57 arsenic trioxide injection 57 MOVIPREP ® 57 oral treprostinil 57 Randomized Double Blind Placebo 57 TH# [003] 57 6R BH4 57 topical calcineurin inhibitors 57 Zemplar Capsules 57 SoftScan ® 57 controlled multicenter Phase 57 Zilver PTX stent 57 Ziprasidone 57 OMS# 57 GW# [003] 57 TAXUS IV 57 oxybutynin gel 57 dosage regimens 57 INSPIRE Trial Phase III 57 Dacogen decitabine 57 VNP#M 57 AVAPRO 57 Heart Failure Patients 57 IMPELLA 57 invasive candidiasis 57 Phase Ib Clinical Trial 57 Anticancer Drug 57 MOLECULAR 57 composite endpoint 57 Atherosclerotic 57 BRIM3 57 Platinol ® 57 FDG-PET/CT 57 gadobutrol 57 TECNIS ® 57 MicroThermX 57 latanoprost 57 Surgical Ablation System 57 briakinumab 57 PROTECT AF 57 brand ciclesonide HFA 57 BST CarGel